What is the recommended dose of Duolin (ipratropium bromide and salbutamol) Respule for a 6.6kg infant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duolin Respule Dosing for a 6.6kg Infant

For a 6.6kg infant, use 0.5 mL (half) of a Duolin Respule (containing 0.25 mg ipratropium bromide and 1.25 mg salbutamol) every 20 minutes for 3 doses during acute exacerbations, then as needed.

Weight-Based Dosing Calculation

  • The standard pediatric dose for ipratropium bromide is 0.25-0.5 mg every 20 minutes for 3 doses in children under 12 years 1, 2
  • For salbutamol (albuterol), the recommended dose is 0.075 mg/kg (minimum 1.25 mg) every 20 minutes for 3 doses 1
  • At 6.6kg, the calculated salbutamol dose would be 0.495 mg (6.6 × 0.075), but the minimum dose is 1.25 mg 1
  • A standard Duolin Respule (3 mL) contains 0.5 mg ipratropium + 2.5 mg albuterol 1
  • For this infant, use 1.5 mL (half a respule) which provides 0.25 mg ipratropium and 1.25 mg salbutamol 1, 2

Administration Protocol

Initial Treatment (First Hour)

  • Administer 1.5 mL every 20 minutes for 3 doses during severe exacerbations 1, 2
  • This provides the minimum effective dose while avoiding excessive beta-agonist exposure in this small infant 1

Maintenance Dosing

  • After initial 3 doses, continue with 1.5 mL every 1-4 hours as needed based on clinical response 1
  • The combination should be used for up to 3 hours in initial management of severe exacerbations 1, 2

Critical Clinical Considerations

When to Use Combination Therapy

  • Do not use ipratropium as first-line therapy; it should be added to salbutamol for severe exacerbations only 1, 2
  • The combination is most beneficial in the emergency department setting for moderate-to-severe bronchospasm 3, 4
  • Once hospitalized, adding ipratropium provides no additional benefit beyond continued salbutamol alone 1, 2

Mixing and Compatibility

  • Duolin components (ipratropium and salbutamol) may be mixed in the same nebulizer without loss of efficacy 1, 2
  • The pre-mixed formulation ensures appropriate dosing ratios 1, 2

Common Pitfalls to Avoid

  • Avoid using full 3 mL respules in infants under 10kg, as this delivers excessive salbutamol (2.5 mg) when the minimum effective dose (1.25 mg) is sufficient 1
  • Do not continue combination therapy after hospital admission; switch to salbutamol alone once stabilized 1, 2
  • Do not use as monotherapy; always ensure salbutamol is the primary bronchodilator with ipratropium as adjunctive therapy 1, 2
  • Monitor for cardiovascular effects (tachycardia) given the infant's small size and potential sensitivity to beta-agonists 1

Monitoring Parameters

  • Assess respiratory rate, oxygen saturation, and work of breathing at 15-minute intervals during initial treatment 3
  • Evaluate clinical response after each dose to determine need for continued therapy 1
  • Be prepared to provide respiratory support if bronchospasm worsens despite treatment 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pediatric Dosage of Ipratropium Bromide (Ipravent)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.